Research Paper Volume 15, Issue 15 pp 7811—7830
A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
Figure 7. Establishment and evaluation of a predictive nomogram. (A) Nomogram based on the risk score of PRGs and clinicopathological parameters. (B) ROC curves of the nomogram for OS prediction at 1, 3, and 5 years in the GEO cohort. (C) Calibration curves of nomogram for OS prediction at 1, 3, and 5 years in the GEO cohort. (D) ROC curves of the nomogram for OS prediction at 1, 3, and 5 years in the TCGA cohort. (E) Calibration curves of nomogram for OS prediction at 1, 3, and 5 years in the TCGA cohort.